Ficoxil 57 mg Chewable Tablets for Dogs

None.

Special precautions for use in animals
As the tablets are flavoured, they should be stored in a safe place out of the reach of
animals.
The recommended dose, as indicated in the dosing table, should not be exceeded.
Use in very young animals, or animals with suspected or confirmed impairment of
renal, cardiac or hepatic function may involve additional risk. If such use cannot be
avoided, those dogs require careful veterinary monitoring.
Avoid use in any dehydrated, hypovolaemic or hypotensive animals, as there is a
potential risk of increased renal toxicity. Concurrent administration of potentially
nephrotoxic drugs should be avoided.
Use this product under strict veterinary monitoring where there is a risk of
gastrointestinal bleeding, or if the animal previously displayed intolerance to NSAIDs.
Renal and/or hepatic disorders have been reported in very rare cases in dogs
administered the recommended treatment dose. It is possible that a proportion of such
cases had sub-clinical renal or hepatic disease prior to the commencement of therapy.
Therefore, appropriate laboratory testing to establish baseline renal or hepatic
biochemistry parameters is recommended prior to and periodically during
administration.
The treatment should be discontinued if any of these signs are observed: repeated
diarrhoea, vomiting, faecal occult blood, sudden weight loss, anorexia, lethargy,
degradation of renal or hepatic biochemistry parameters.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
This product may be harmful following accidental ingestion.
In order to prevent children from accessing the product, tablets should be administered
and stored out of sight and reach of children. Halved or quartered tablets should be
returned to the open blister pocket and inserted into the outer carton.
Laboratory studies in rats and rabbits have shown evidence that firocoxib has the
potential to effect reproduction and to induce malformations in foetuses. Pregnant
women or women who are intending to become pregnant should administer the
product with caution.
Wash hands after use of the product.

Revised: November 2025
AN: 02244/2025
In the event of accidental ingestion of one or more tablets, seek medical advice
immediately and show the package leaflet or the label to the doctor.